Emerging Nanotechnologies in Immunology
The Design, Applications and Toxicology of Nanopharmaceuticals and Nanovaccines
- 1st Edition - May 17, 2018
- Editors: Ranjita Shegokar, Eliana B. Souto
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 4 0 0 1 6 - 9
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 4 0 1 1 3 - 5
Emerging Nanotechnologies in Immunology aims to deliver a systematic and comprehensive review of data concerning the nature of interaction and nano-related risks between the nanoph… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe scientific development of manufactured nanomaterials for drug delivery is increasing rapidly. One of the most prominent applications is topical drug delivery, where cutaneous, ocular, and nasal exposure becomes even more relevant. These targets are the first barrier that nanoparticles encounter when in contact with the human body.
The contributors addresses a representative set of the broad spectrum of nanopharmaceuticals currently being used, including cationic lipid nanoparticles, polymeric PLGA, PLA nanoparticles, biomacromolecules-based nanoparticles, and other scaffolds tissue engineered skin substitutes. Regulation and risk is also covered, since the safety of these nanophamaceuticals still represents a barrier to their wide innovative use.
- Provides the reader with a thorough knowledge of the safety aspects of nanopharmaceuticals which are currently under research
- Focuses on the characterization and quantification of the nanopharmaceuticals
- Allows readers to understand the correlation between the nature of the materials and their potential nanotoxicological effects
- Includes an overview of regulatory aspects related to the R&D of nanopharmaceuticals
- No. of pages: 290
- Language: English
- Edition: 1
- Published: May 17, 2018
- Imprint: Elsevier
- Hardback ISBN: 9780323400169
- eBook ISBN: 9780323401135
RS
Ranjita Shegokar
Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)
ES